The Tumor-Specific De2–7 Epidermal Growth Factor Receptor (EGFR) Promotes Cells Survival and Heterodimerizes With the Wild-Type EGFR

Oncogene - United Kingdom
doi 10.1038/sj.onc.1207870
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-Ubiquitination Promotes EGFR Degradation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but Not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors

Cancer Research
Cancer ResearchOncology
2006English

Epidermal Growth Factor Receptor (EGFR) Signaling Promotes Proliferation and Survival in Osteoprogenitors by Increasing Early Growth Response 2 (EGR2) Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

Responses of Cancer Cells With Wild-Type or Tyrosine Kinase Domain-Mutated Epidermal Growth Factor Receptor (EGFR) to EGFR-targeted Therapy Are Linked to Downregulation of Hypoxia-Inducible Factor-1α

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2007English

Hypermethylated Epidermal Growth Factor Receptor (EGFR) Promoter Is Associated With Gastric Cancer

Scientific Reports
Multidisciplinary
2015English

Epidermal Growth Factor Receptor (EGFR); EGFR1 (HER1; ERBB1); EPH Receptor A2 (EPHA2)

Science-Business eXchange
2011English

AXL/epidermal Growth Factor Receptor (EGFR) Complexes in Breast Cancer - Culprits for Resistance to EGFR Inhibitors?

Breast Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy